Using the chromatin immunoprecipitation assay, we confirmed the identification of a set of new E2F target genes. As a second approach, we have used the chromatin immunoprecipitation protocol to ...

The poster will present new mechanistic insights into the anti-cancer activity of cyclin A/B RxL inhibitors, including their impact on DNA repair pathways and mitotic progression in E2F-high cancers.